In this study, we demonstrated that a novel humanized anti-IL-6 mAb HZ-0408b potently binds to IL-6, specifically inhibits IL-6 signaling, and can ameliorate established arthritis in CIA cynomolgus monkeys. This evidence concerns the gene IL6 and arthritic joint disease.